Artemis Medicare Services profit and loss

Latest FY26

Revenue: ₹1,081cr+15.4% on FY25
EBITDA: ₹188cr+24.0% on FY25
Net profit: ₹104cr+26.2% on FY25
EPS: ₹6.56+22.2% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,114	1,081	937	879	737	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	28.3	29.8	33.0	7.4	7.3
	1,142	1,111	970	886	745
	249	254	227	219	195
	0.0	0.0	0.0	0.0	0.0
	0.0	0.0	0.0	0.0	−0.0
	171	166	148	139	121
	26.8	27.7	31.9	31.3	19.7
	49.6	48.1	45.2	40.3	31.0
	491	473	409	388	328
	987	969	862	817	694
	203	188	152	133	93.9
	154	140	107	92.4	62.9
Profit
	155	142	108	68.5	50.6
	−3.1	−3.1	0.0	0.0	0.0
	152	139	108	68.5	50.6
	32.3	29.0	21.3	12.7	8.5
	5.7	6.4	4.2	6.7	4.1
	38.1	35.5	25.5	19.3	12.6
	114	104	82.2	49.1	38.0
	114	104	82.2	49.1	38.0
	−0.2	−0.2	−0.1	−0.2	0.9
	114	104	82.1	49.0	38.9
	114	104	82.6	49.1	35.9
	0.3	0.1	−0.4	0.0	0.6
Per share
	₹7.19	₹6.56	₹5.37	₹3.62	₹2.89
	₹7.18	₹6.56	₹5.31	₹3.53	₹2.79
Other comprehensive income — detail
	−0.2	−0.2	−0.1	—	—
	−0.4	−0.4	−0.3	−0.4	1.1
	−0.2	−0.2	−0.2	—	—
	—	—	—	−0.3	0.2
	113	103	82.5	49.0	39.5
	0.3	0.1	−0.5	0.0	−0.6
Per share — as-filed variants
	₹7.19	₹6.56	₹5.37	₹3.62	₹2.89
	₹7.18	₹6.56	₹5.31	₹3.53	₹2.79
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	864	827	709	660	543
	77.6%	76.5%	75.7%	75.1%	73.6%
Adjusted (ex-exceptional items) — derived
	155	142	108	68.5	50.6
	−3.1	−3.1	0.0	0.0	0.0
	116	106	82.2	49.1	38.0
	₹7.34	₹6.70	₹5.37	₹3.62	₹2.89

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ARTEMISMED₹297.95

Artemis Medicare Services Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersINDRAMEDCO SHALBY GKSL GPTHEALTH LOTUSEYE DRAGARWQ KMCSHIL KOVAIMcap ₹4,717 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	737.4	878.6	936.9	1,081.2	1,113.6
Other Income	7.3	7.4	33.0	29.8	28.3
Total Income	744.8	885.9	969.9	1,111.1	1,141.9
Expenses
+ Cost of Materials Consumed	194.9	218.7	227.4	253.9	249.1
+ Purchases of Stock-in-Trade	0.0	0.0	0.0	0.0	0.0
+ Changes in Inventories	-0.0	0.0	0.0	0.0	0.0
+ Employee Benefit Expense	120.8	138.9	148.4	166.1	170.5
+ Finance Costs	19.7	31.3	31.9	27.7	26.8
+ Depreciation & Amortisation	31.0	40.3	45.2	48.1	49.6
+ Other Expenses	327.8	388.3	409.3	473.1	490.8
Total Expenses	694.2	817.5	862.2	968.8	986.8
EBITDA	93.9	132.7	151.8	188.2	203.2
EBIT	62.9	92.4	106.6	140.1	153.6
Profit
PBT before Exceptional Items	50.6	68.5	107.7	142.3	155.1
+ Exceptional Items	0.0	0.0	0.0	-3.1	-3.1
Pretax Income	50.6	68.5	107.7	139.2	152.0
+ Current Tax	8.5	12.7	21.3	29.0	32.3
+ Deferred Tax	4.1	6.7	4.2	6.4	5.7
Tax Expense	12.6	19.3	25.5	35.5	38.1
Net Income	38.0	49.1	82.2	103.7	114.0
+ Net Income — Continuing Ops	38.0	49.1	82.2	103.7	114.0
+ Other Comprehensive Income	0.9	-0.2	-0.1	-0.2	-0.2
Total Comprehensive Income	38.9	49.0	82.1	103.5	113.8
Net Income to Common	35.9	49.1	82.6	103.6	113.7
Minority Interest	0.6	0.0	-0.4	0.1	0.3
Per Share
Basic EPS	2.89	3.62	5.37	6.56	7.19
Diluted EPS	2.79	3.53	5.31	6.56	7.18
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.1	-0.2	-0.2
+ Items NOT to be Reclassified to P&L	1.1	-0.4	-0.3	-0.4	-0.4
+ Tax on Items NOT to be Reclassified	—	—	-0.2	-0.2	-0.2
+ Tax on Items NOT to be Reclassified — alt tag	0.2	-0.3	—	—	—
Comprehensive Income — Owners of Parent	39.5	49.0	82.5	103.4	113.5
Comprehensive Income — Non-controlling Interests	-0.6	0.0	-0.5	0.1	0.3
Per Share — as-filed variants
Basic EPS — Continuing Operations	2.89	3.62	5.37	6.56	7.19
Diluted EPS — Continuing Operations	2.79	3.53	5.31	6.56	7.18
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	542.5	659.9	709.5	827.4	864.5
Gross Margin %	73.57	75.11	75.72	76.52	77.63
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	50.6	68.5	107.7	142.3	155.1
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-3.1	-3.1
Net Income Adj (tax-effected)	38.0	49.1	82.2	106.0	116.3
EPS Adj	2.89	3.62	5.37	6.70	7.34
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	13.4	13.6	13.8	15.8	15.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.